You are conducting a study to determine the effects of
chemotherapy on the survival of subjects with pancreatic carcinoma.
Subjects are enrolled at diagnosis and treated immediately after
staging. You observed 5 subjects for an average of 12 months each
before the occurrence of death, loss to follow-up, or study
termination; 3 of these subjects die. You observe 10 subjects for
an average of 6 months each, and 5 die. You observe 10 subjects for
an average of 18 months each, and 7 die. What is the total
observation period?